$CAPR News Article - Capricor Therapeutics to Present One-Year Efficacy Results from its Ongoing HOPE-2 Open Label Extension Study at 2022 Parent Project Muscular Dystrophy Annual Conference https://marketwirenews.com/news-releases/capr...85640.html